Characterization and differential in vivo regulation of brain adrenergic receptor subtypes.
D000320:Adrenergic Fibers / Q000378:metabolism; D000317:Adrenergic alpha-Antagonists / Q000378:metabolism; D000420:Albuterol / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism*; D002531:Cerebellum / Q000378:metabolism; D004082:Dihydroalprenolol / Q000378:metabolism; D004146:Dioxanes / Q000378:metabolism; D006892:Hydroxydopamines / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D011217:Practolol / Q000378:metabolism; D051381:Rats; D011941:Receptors, Adrenergic / Q000378:metabolism*; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism*; D011943:Receptors, Adrenergic, beta / Q000378:metabolism*; D013564:Sympathetic Nervous System / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D006892:Hydroxydopamines; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D004082:Dihydroalprenolol; C010654:(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane; D000420:Albuterol; D011217:Practolol; D009638:Norepinephrine